Insulin Lilly Huminsulin Basal KwikPen stylo prérempli
Insulin Lilly Huminsulin Basal KwikPen stylo prérempli is a medicine authorised by Swissmedic under authorisation number 61550. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 August 2011 and the authorisation is valid without a time limit. ATC code A10AC01 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 61550 |
|---|---|
| Name | Insulin Lilly Huminsulin Basal KwikPen stylo prérempli |
| Full name | Insulin Lilly Huminsulin Basal KwikPen stylo prérempli, suspension injectable |
| Authorisation holder | Eli Lilly (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AC01 |
| First authorisation | 16 August 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Insulin Lilly Huminsulin Basal KwikPen stylo prérempli, suspension injectable | B | 16 August 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 x 3,0 | ml | A10AC01 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Insulin Lilly Huminsulin Basal KwikPen stylo prérempli authorised in Switzerland?
Yes. Insulin Lilly Huminsulin Basal KwikPen stylo prérempli is authorised by Swissmedic under authorisation number 61550, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Insulin Lilly Huminsulin Basal KwikPen stylo prérempli have?
Insulin Lilly Huminsulin Basal KwikPen stylo prérempli is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Insulin Lilly Huminsulin Basal KwikPen stylo prérempli?
The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.